This comprehensive supplement brings together a series of articles, insights and discussions produced by Kantar Health in order to help stimulate debate and fresh thinking about the future of p
With more than 80 per cent of European doctors saying they want to stay abreast of new developments about pharmaceutical products, it is important to understand how they wish to receive this in
Preparation is key to creating and maintaining a strong drugs pipeline. However, the statistics demonstrate that successful product commercialisation strategies are not always implemented.
While every pharma company recognises the potential of multichannel marketing to optimize its engagement with prescribers, many are yet to implement it to maximum potential.
While pharma observers speculate on the death of outdated drug discovery and sales models, some critical wounds to brand marketing have been largely ignored.
As the pharma industry scrutinizes every aspect of its operations in the drive for greater efficiency, the processes behind marketing have so far seen little impact.